Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 143.7 EUR -1.88%
Market Cap: 62.5B EUR
Have any thoughts about
Merck KGaA?
Write Note

Merck KGaA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Merck KGaA
Cash & Cash Equivalents Peer Comparison

Comparables:
ATAI
BAYN
93M1
DMP
PSG

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Merck KGaA
XETRA:MRK
Cash & Cash Equivalents
€2.7B
CAGR 3-Years
14%
CAGR 5-Years
-5%
CAGR 10-Years
12%
ATAI Life Sciences NV
NASDAQ:ATAI
Cash & Cash Equivalents
$45m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Cash & Cash Equivalents
€3.9B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
12%
MPH Health Care AG
XETRA:93M1
Cash & Cash Equivalents
€4.6m
CAGR 3-Years
131%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Cash & Cash Equivalents
€165.8m
CAGR 3-Years
18%
CAGR 5-Years
15%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Cash & Cash Equivalents
€40.8m
CAGR 3-Years
72%
CAGR 5-Years
-12%
CAGR 10-Years
N/A

See Also

What is Merck KGaA's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.7B EUR

Based on the financial report for Jun 30, 2024, Merck KGaA's Cash & Cash Equivalents amounts to 2.7B EUR.

What is Merck KGaA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
12%

Over the last year, the Cash & Cash Equivalents growth was 52%. The average annual Cash & Cash Equivalents growth rates for Merck KGaA have been 14% over the past three years , -5% over the past five years , and 12% over the past ten years .

Back to Top